Requires insurers to deposit certain funds into the reproductive health care access fund; and establishes the reproductive health care access fund
This bill creates a new funding mechanism for reproductive health care in New York. It requires certain insurers, nonprofit health service plans, and health maintenance organizations to segregate and then transfer specified premium funds associated with ACA-compliant coverage into a newly established Reproductive Health Care Access Fund. The bill also directs that a portion of unused balances in those segregated accounts be redirected to support reproductive health care clinical services, including services for which federal funds are prohibited from being used.
The bill amends the Insurance Law, State Finance Law, and Public Health Law. It establishes the Reproductive Health Care Access Fund in the joint custody of the state comptroller and commissioner of taxation and finance, and ties the fund to the existing reproductive freedom and equity grant program. It also requires annual reporting by insurers and state agencies, creates transfer deadlines and appeal rights, and directs that the governor include an appropriation of at least 50 percent of the fund in the executive budget beginning in fiscal year 2029. The Public Health Law amendment prioritizes grant funding for providers and applicants that have not previously received assistance.
Overall, the bill appears intended to expand and stabilize funding for reproductive health care services by capturing unused insurance-related balances and channeling them into a dedicated state fund. Its practical effect would be to impose new accounting, reporting, and transfer obligations on regulated insurers and health plans, while increasing the resources available to reproductive health care providers and grant recipients. The bill would take effect January 1, 2027.
Because there are no committee transcripts or recorded votes provided, the available context shows limited direct evidence of legislative debate. The bill’s introduction and referral to the Assembly Insurance Committee suggest it is still early in the process. The caption and structure indicate a policy goal of supporting reproductive health access, and the bill text itself is detailed and implementation-focused rather than exploratory.
The main point of potential contention is the redirection of insurer-held premium funds into a state-administered reproductive health fund, which may raise concerns among insurers about administrative burden, accounting requirements, and the scope of state control over segregated balances. Supporters would likely emphasize expanded access to reproductive care, dedicated funding, and prioritization of providers with less prior grant support. No recorded opposition or support is included in the provided materials.
The bill would add a new section 3246 to the Insurance Law, create section 99-uu of the State Finance Law, and amend the Public Health Law grant program governing reproductive health care funding. It would require covered insurers and health plans to track, report, and transfer certain unused ACA-related premium funds into a state reproductive health care access fund, with the superintendent of financial services overseeing compliance and transfers. The bill would also change how grant funds are allocated by prioritizing providers and applicants that have not previously received assistance, and it would require a minimum executive budget appropriation tied to the new fund beginning in fiscal year 2029.
The bill’s overall sentiment appears supportive of reproductive health access and funding expansion. Its text is structured to create a dedicated revenue stream, strengthen grant support, and ensure ongoing reporting and oversight, which suggests a policy objective of building a durable funding source rather than making a temporary appropriation. Because there are no transcripts or votes, there is no documented floor or committee sentiment beyond the bill’s introduction and referral, but the measure’s design indicates a pro-access, pro-funding orientation.
The likely contention centers on the requirement that insurers and health plans segregate and transfer funds derived from ACA-related coverage into a state fund, which may be viewed as a regulatory and financial burden by covered entities. Another possible point of dispute is the use of funds for reproductive health services, particularly services for which federal funds are prohibited, which could draw ideological opposition. Supporters are likely to focus on access, dedicated funding, and prioritization of underfunded providers, while critics may question the funding mechanism, administrative complexity, and state authority over the balances.